Skip to main content
Premium Trial:

Request an Annual Quote

Structural Bioinformatics Pens Protein Structure Deal with RW Johnson

NEW YORK, Jan 25 – Structural Bioinformatics said Thursday that it had reached a deal to “elucidate” protein structures for The RW Johnson Pharmaceutical Research Institute, a subsidiary of Johnson & Johnson.

“We are extremely pleased to begin a relationship with The R.W. Johnson
Pharmaceutical Research Institute on target structure elucidation,” Edward Maggio, CEO of SBI, said in a statement.

SBI did not disclose financial details or say what targets SBI would work on. The company could not immediately be reached for comment.

In the statement, SBI said it would provide RW Johnson with access to SBI's x-ray crystallography program for “several” undisclosed targets in its drug discovery efforts. Details about SBI’s x-ray crystallography program could not immediately be ascertained. In the past, the company has tended to downplay the need to use x-ray crystallography, focusing attention on its ability to generate protein structures in silico .

SBI is a privately held company based in San Diego.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.